Valeant Freefall Calls Equity
Deals Into Question
Summary | The plunge in Valeant Pharmaceuticals International
Inc.'s stock price serves as a cautionary tale for target
companies: Beware of stock offers.
blogs.wsj.com | 09 January 2016